NCT04195412

Brief Summary

Functional and structural magnetic resonance imaging (MRI) will be used to investigate neural correlates of bihemispheric transcranial direct current stimulation (tDCS) associated with upper limb rehabilitation in chronic stroke patients. For this purpose, patients included will be submitted to 10 sessions with active or sham bihemispheric tDCS associated with intensive and individualized rehabilitation. Neuroimage will be employed before and after the intervention to investigate neural correlates of expected changes in motor function.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for phase_2 stroke

Timeline
Completed

Started Oct 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 29, 2019

Completed
Same day until next milestone

Study Start

First participant enrolled

October 29, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 11, 2019

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2021

Completed
Last Updated

December 11, 2019

Status Verified

December 1, 2019

Enrollment Period

11 months

First QC Date

October 29, 2019

Last Update Submit

December 9, 2019

Conditions

Keywords

Stroke RehabilitationTranscranial Direct Current StimulationNeuroimagingNeuronal Plasticity

Outcome Measures

Primary Outcomes (2)

  • Treatment-related changes in functional magnetic resonance imaging

    Brain functional changes from baseline to post-treatment

    pre-treatment (baseline), post-treatment (from 3 to 7 days after the end of the treatment)

  • Treatment-related changes in white matter

    Brain structural (white matter) changes from baseline to post-treatment

    pre-treatment (baseline), post-treatment (from 3 to 7 days after the end of the treatment)

Secondary Outcomes (3)

  • Changes in Fugl-Meyer assessment of paretic upper limb motor function

    pre-treatment (baseline), post-treatment (from 3 to 7 days after the end of the treatment); 30 days follow up (30 days after completing treatment) and 90 days follow up (90 days after completing treatment)

  • Changes in Jebsen-Taylor Hand Function Test scores

    pre-treatment (baseline), post-treatment (from 3 to 7 days after the end of the treatment), follow-up 30 days, follow-up 90 days

  • Changes in Stroke Impact Scale scores

    pre-treatment (baseline), post-treatment (from 3 to 7 days after the end of the treatment), follow-up 30 days, follow-up 90 days

Study Arms (2)

tDCS

EXPERIMENTAL

Bihemispheric tDCS will be applied. The anode will be placed on the affected hemisphere, while the cathode will be positioned over the unaffected hemisphere. After stimulation, individual and intensive upper limb rehabilitation will be performed.

Device: tDCS + upper limb rehabilitation

Control

SHAM COMPARATOR

Bihemispheric sham tDCS will be applied. The anode will be placed on the affected hemisphere, while the cathode will be positioned over the unaffected hemisphere. After sham stimulation, individual and intensive upper limb rehabilitation will be performed.

Device: Sham tDCS + upper limb rehabilitation

Interventions

Stimulation will be applied for 20 minutes by a DC stimulator (NeuroConn, Germany). During each stimulation section, a pair of saline-soaked sponge electrodes (surface 24 cm²) will be placed over C3 and C4, according to the International 10-20 EEG system. Stimulation intensity will be 2 mA with current ramping up and down of 10 seconds each. The stimulation will be followed by 40 minutes of upper limb rehabilitation. Experimental sessions will be repeated five times per week to complete 10 sessions.

tDCS

Sham stimulation will be applied for 20 minutes by a DC stimulator (NeuroConn, Germany). During each sham stimulation section, a pair of saline-soaked sponge electrodes (surface 24 cm²) will be placed over C3 and C4, according to the International 10-20 EEG system. The anode will be placed to the affected hemisphere, while the cathode will be positioned over the unaffected hemisphere. Sham tDCS will be performed by ramping current flow for the first 10 seconds of stimulation, but switching the stimulator off automatically after 30 seconds. The sham stimulation will be followed by 40 minutes of upper limb rehabilitation. Experimental sessions will be repeated five times per week to complete 10 sessions.

Control

Eligibility Criteria

Age30 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Chronic Stroke (\> 12 months)
  • Upper limb sensorimotor sequelae due to stroke affecting only one cerebral hemisphere
  • The structural integrity of the corpus callosum sensorimotor
  • Showing ability to perform some movement with the paretic upper limb: at least minimal active mobility of the wrist and two fingers of the paretic hand.
  • Score ≥ 18 at Folstein Mini-Mental State Examination

You may not qualify if:

  • Score ≥ 4 at Ashworth Scale
  • MRI or tDCS contraindications (cardiac pacemakers; implanted medication pumps; cochlear, or eye implants; craniotomy, skin lesions at the site of stimulation; surgical clips in or near the brain; claustrophobia, history of seizures, permanent makeup or tattoos with metallic dyes…)
  • Prior neurological diseases
  • Hemodynamic instability
  • Pregnancy
  • Traumatic or orthopedic lesion limiting the range of upper limb motion
  • Severe comprehension deficits, apraxia or neglect that would interfere with performing the study tasks
  • Score \> 59 at the Fugl-Meyer Assessment of Motor Recovery after Stroke

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

D'Or Institute for Research and Education (IDOR)

Rio de Janeiro, 22281100, Brazil

RECRUITING

MeSH Terms

Conditions

Stroke

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Fernanda F Tovar-Moll, PhD

    D'Or Institute for Research and Education (IDOR)

    STUDY DIRECTOR
  • Erika C Rodrigues, PhD

    D'Or Institute for Research and Education (IDOR)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Erika C Rodrigues, PhD

CONTACT

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 29, 2019

First Posted

December 11, 2019

Study Start

October 29, 2019

Primary Completion

October 1, 2020

Study Completion

October 1, 2021

Last Updated

December 11, 2019

Record last verified: 2019-12

Locations